Γ
Content Highlights || Full Agenda
Breakout Session

•

3:30 PM

-

4:15 PM

Human Health

Skip the Assembly, Go Straight to Your Next Breakthrough: How Innovative DNA Synthesis Is Changing What's Possible in Biopharma

The synthetic DNA field has entered an era of rapid innovation that is giving biopharma scientists new options when deciding whether to build or buy long and complex DNA. Previously hard-to-source DNA constructs are now readily available with an unprecedented guarantee for on-time shipping, eliminating procurement delays and empowering researchers to push the boundaries of synthetic biology. In this session, leading scientists will discuss how these advances are expanding design possibilities, accelerating design–build–test–learn cycles, and paving the way for the next wave of precision biotherapeutics.

Get a Ticket

Join

Featuring

Christopher Vakulskas

Integrated DNA Technologies

Sr. Dir. of Enzyme Dev.

Derek Smith

Gilead Sciences

Principal Scientist

Colin Harvey

Hexagon Bio

Co-founder & VP, Early Discovery

Geoff Hamilton

Ansa Biotechnologies

Chief Business & CFO

Breakout Session

•

3:30 PM

-

4:15 PM

Human Health

Skip the Assembly, Go Straight to Your Next Breakthrough: How Innovative DNA Synthesis Is Changing What's Possible in Biopharma

The synthetic DNA field has entered an era of rapid innovation that is giving biopharma scientists new options when deciding whether to build or buy long and complex DNA. Previously hard-to-source DNA constructs are now readily available with an unprecedented guarantee for on-time shipping, eliminating procurement delays and empowering researchers to push the boundaries of synthetic biology. In this session, leading scientists will discuss how these advances are expanding design possibilities, accelerating design–build–test–learn cycles, and paving the way for the next wave of precision biotherapeutics.

Get a Ticket

Join

Featuring

Christopher Vakulskas

Integrated DNA Technologies

Sr. Dir. of Enzyme Dev.

Derek Smith

Gilead Sciences

Principal Scientist

Colin Harvey

Hexagon Bio

Co-founder & VP, Early Discovery

Geoff Hamilton

Ansa Biotechnologies

Chief Business & CFO

Back to Full Schedule

Back to Full Schedule

SynBioBeta is where the people building with biology meet the people funding, buying, and partnering with them. If you're raising capital, scouting the next wave of AIxBIO companies, or looking for your next technology partner - the people you need are here for three days.

The startups on stage this year are building programmable RNA medicines, virtual cell models, AI-designed enzymes, and proteins that replace sugar - alongside GSK, Sanofi, Novo Nordisk, Eli Lilly, J&J, Mars, Apple, Google, NVIDIA, Unilever, and P&G.

Watching where the partnerships form and which technologies the biggest players are actually evaluating is something you can't get from a report or a webinar. And our 1:1 Partnering App lets you book meetings before you arrive.

“SynBioBeta is a who’s who of AI and biology.
This is where the future is being built, so don't miss it”
“SynBioBeta is a who’s who of AI and biology.
This is where the future is being built, so don't miss it”

Eric Schmidt

Former CEO

"For every single fund at Boom Capital, one of our best companies has come directly from SynBioBeta. I met Mammoth Bio at SynBioBeta, and I met Nabla Bio at SynBioBeta."

Celestine Schnugg

Founder

"Nabla was accelerated into existence because of SynBioBeta. I met Seth Bannon from 50 Years, Cee Cee Schnugg from Boom Capital, and others from Y Combinator there, and those same people seeded Nabla. The vibe, leverage, and energy at SynBioBeta are unreal."
"Nabla was accelerated into existence because of SynBioBeta. I met Seth Bannon from 50 Years, Cee Cee Schnugg from Boom Capital, and others from Y Combinator there, and those same people seeded Nabla. The vibe, leverage, and energy at SynBioBeta are unreal."

Surge Biswas

Founder

"Our Series A came together because of a little bit of SynBioBeta magic. I’ve been attending for a decade and it’s been inspiring to watch the field evolve from a lot of hopes and dreams to real products and applications."
"Our Series A came together because of a little bit of SynBioBeta magic. I’ve been attending for a decade and it’s been inspiring to watch the field evolve from a lot of hopes and dreams to real products and applications."

Jacob Glanville

Founder & CEO

"I met Algen at SynBioBeta and later invested in the company. It’s exactly the kind of connection that makes the community so valuable."
"I met Algen at SynBioBeta and later invested in the company. It’s exactly the kind of connection that makes the community so valuable."

Bill Tai

Co-founder

"At SynBioBeta I met the team at Biomatter, an AI-driven enzyme design company. The environment made it easy to start a real conversation. That conversation turned into a collaboration to improve one of our enzymes. We're now exploring entirely new performance possibilities together."
"At SynBioBeta I met the team at Biomatter, an AI-driven enzyme design company. The environment made it easy to start a real conversation. That conversation turned into a collaboration to improve one of our enzymes. We're now exploring entirely new performance possibilities together."

Luis Cascao-Pereira

Head of Digital Biology

"Every time I attend SynBioBeta, I walk away with something transformative – a new investor, a fantastic hire, or an idea that changes how we work. It’s a community unlike any other."
"Every time I attend SynBioBeta, I walk away with something transformative – a new investor, a fantastic hire, or an idea that changes how we work. It’s a community unlike any other."

Ola Wlodek

CEO

Who’s Coming to SynBioBeta?

Funders writing checks and looking for their next company.

Jenny Rooke

Genoa Ventures

Managing Director

Jenny Rooke

Genoa Ventures

Managing Director

Jessica Owens

Initiate Ventures

Managing Partner

Jessica Owens

Initiate Ventures

Managing Partner

Alicia Jackson

ARPA-H

Director

Alicia Jackson

ARPA-H

Director

Elliot Hershberg

Amplify Partners

Partner, Author

Elliot Hershberg

Amplify Partners

Partner, Author

Liliana Nordbakk

NEVA SGR

Partner

Liliana Nordbakk

NEVA SGR

Partner

Omri Amirav-Drory

NFX

General Partner

Omri Amirav-Drory

NFX

General Partner

Michael Koeris

DARPA

Director, BTO

Michael Koeris

DARPA

Director, BTO

David Welch

Synthesis Capital

CSO & Co-founder

David Welch

Synthesis Capital

CSO & Co-founder

Shelby Newsad

Compound

Partner

Shelby Newsad

Compound

Partner

Lauren Greenlee

XPRIZE

EVP

Lauren Greenlee

XPRIZE

EVP

Alice Pettitt

ARIA

Frontier Specialist

Alice Pettitt

ARIA

Frontier Specialist

Jessica Green

ARPA-H

PM, Resilient Systems

Jessica Green

ARPA-H

PM, Resilient Systems

Kit McDonnell

Superorganism VC

Head of Ecosystem

Kit McDonnell

Superorganism VC

Head of Ecosystem

The Startups they'll be meeting with.

Marc Tessier-Lavigne

Xaira

Chairman & CEO

Marc Tessier-Lavigne

Xaira

Chairman & CEO

Ron Alfa

NOETIK Inc.

Co-Founder & CEO

Ron Alfa

NOETIK Inc.

Co-Founder & CEO

Christina Smolke

Antheia

CEO & Co-Founder

Christina Smolke

Antheia

CEO & Co-Founder

Simon Kohl

Latent Labs

Founder & CEO

Simon Kohl

Latent Labs

Founder & CEO

Jen Asher

1910

Founder & CEO

Jen Asher

1910

Founder & CEO

Ola Wlodek

Constructive Bio

CEO

Ola Wlodek

Constructive Bio

CEO

Daniel de la Torre

Constructive Bio

VP of R&D

Daniel de la Torre

Constructive Bio

VP of R&D

Elise de Reus

Cradle

Co-founder

Elise de Reus

Cradle

Co-founder

Alexandre Zanghellini

Arzeda

Co-founder & CEO

Alexandre Zanghellini

Arzeda

Co-founder & CEO

Jacob Glanville

Centivax

CEO

Jacob Glanville

Centivax

CEO

Micha Breakstone

Cellular Intelligence

Co-founder & CEO

Micha Breakstone

Cellular Intelligence

Co-founder & CEO

Eric Kelsic

Dyno Therapeutics

CEO

Eric Kelsic

Dyno Therapeutics

CEO

Emily Leproust

Twist Bioscience

CEO

Emily Leproust

Twist Bioscience

CEO

Gabriele Corso

Boltz

CEO

Gabriele Corso

Boltz

CEO

Matt Angle

Paradromics

Founder & CEO

Matt Angle

Paradromics

Founder & CEO

Eric Nguyen

Radical Numerics

Co-founder & CEO

Eric Nguyen

Radical Numerics

Co-founder & CEO

Peyton Greenside

BigHat Biosciences

CEO & Co-Founder

Peyton Greenside

BigHat Biosciences

CEO & Co-Founder

And the BD and R&D Leads
That Will Be Your Customers and Partners:

Mikah Coffindaffer

Procter & Gamble

R&D Director

Mikah Coffindaffer

Procter & Gamble

R&D Director

Neil Parry

Unilever

R&D Dir. Biotech

Neil Parry

Unilever

R&D Dir. Biotech

Gregory Hocking

Mars Snacking

VP Global R&D New Innov. Territories

Gregory Hocking

Mars Snacking

VP Global R&D New Innov. Territories

Ling Li

ADM

Dir. Market Dev., Prec. Ferm.

Ling Li

ADM

Dir. Market Dev., Prec. Ferm.

Kim Branson

GlaxoSmithKline

SVP, Global Head

Kim Branson

GlaxoSmithKline

SVP, Global Head

Vikram  Agarwal

Sanofi

Head of mRNA Platform Design Data Science

Vikram  Agarwal

Sanofi

Head of mRNA Platform Design Data Science

Peter Clark

Novo Nordisk

VP, CDD

Peter Clark

Novo Nordisk

VP, CDD

Amy Jenkins

AstraZeneca

Sr Dir, Strat & Ops

Amy Jenkins

AstraZeneca

Sr Dir, Strat & Ops

Susan Klaeger

Genentech

Principal Scientist

Susan Klaeger

Genentech

Principal Scientist

Kristina Kitko

Eli Lilly

Director of Venture

Kristina Kitko

Eli Lilly

Director of Venture

Ekaterine Kortkhonjia

J&J

Sr. Dir, Transactions

Ekaterine Kortkhonjia

J&J

Sr. Dir, Transactions

Josh Armstrong

Corteva

Discovery & Bioprocess Leader

Josh Armstrong

Corteva

Discovery & Bioprocess Leader

Lyle Ralston

Bayer Crop Science

CE Platform Lead

Lyle Ralston

Bayer Crop Science

CE Platform Lead

Leah Briscoe

Bayer Crop Science

Data Scientist

Leah Briscoe

Bayer Crop Science

Data Scientist

Tommi White

Bayer Crop Science

Structure & Mech. Team Lead

Tommi White

Bayer Crop Science

Structure & Mech. Team Lead

Paramita Deria

Bayer Crop Science

Discovery Chem. & Chem. Biology

Paramita Deria

Bayer Crop Science

Discovery Chem. & Chem. Biology

Alberto Iandolino

Bayer Crop Science

Ext. Innov. & Partnership - Biologics

Alberto Iandolino

Bayer Crop Science

Ext. Innov. & Partnership - Biologics

Colby Adolph

Evonik

Sales Director

Colby Adolph

Evonik

Sales Director

Laura Kliman

Impossible Foods

Senior R&D Director

Laura Kliman

Impossible Foods

Senior R&D Director

Paul Bielewicz

W. L. Gore & Associates

Dir. of Innov. & Venture Dev.

Paul Bielewicz

W. L. Gore & Associates

Dir. of Innov. & Venture Dev.

Riccardo LoCascio

Novonesis

Partnering - Precision Proteins

Riccardo LoCascio

Novonesis

Partnering - Precision Proteins

Cynthia Collins

Ginkgo Bioworks

GM, Ginkgo Reagents

Cynthia Collins

Ginkgo Bioworks

GM, Ginkgo Reagents

Get a Ticket

Get a Ticket